wellrank.ai
Sign In

Compounded semaglutide vs brand name: what is the difference and is it safe?

ClaudecomparisonCollected Oct 30, 2026, 21:00 UTC

Verbatim response from Claude

Compounded vs. Brand Name Semaglutide

Brand Name Options

  • Ozempic (injection, approved for type 2 diabetes)
  • Wegovy (injection, approved for weight loss)
  • Rybelsus (oral, approved for type 2 diabetes)

These are manufactured by Novo Nordisk under strict FDA oversight with guaranteed purity, dosage accuracy, and safety testing.


Compounded Semaglutide

Pharmacies like Empower Pharmacy, Hallandale Health, and Strive Pharmacy have produced compounded versions, typically much cheaper.

Key Differences:

FactorBrand NameCompounded
FDA approval✅ Yes❌ No
Quality testingRigorousVaries widely
Cost$900-$1,300/month$100-$400/month
ConsistencyGuaranteedNot guaranteed

Safety Concerns

  • The FDA has issued warnings about compounded semaglutide, noting contamination risks and dosing errors
  • Some compounders used semaglutide salt (different form) rather than the base compound
  • Quality varies significantly between pharmacies
  • Now that shortages have ended, the FDA is phasing out legal compounding of semaglutide

Bottom Line

Brand name is safer if you can afford it or have insurance coverage. If considering compounded, use only FDA-registered 503B outsourcing facilities and consult your doctor.

Brands mentioned in this answer

More GLP-1 weight loss answers

See all GLP-1 weight loss rankings and answers →

Is this answer wrong about your brand?

AI engines repeat outdated pricing, wrong ingredients, and misread positioning every day. Tell us what this answer gets wrong and we will include a correction review in your free AI Visibility Audit.

This answer is reproduced verbatim from the engine's API at collection time and may contain errors or outdated claims. It is presented as evidence of what AI engines tell buyers, not as medical or purchasing advice.

Is your brand missing from this answer?

Get your AI Visibility Audit: every buyer intent question you are losing, who wins them, and the sources that decide the answer.